Skip to content

Clinical utility of rapid genome sequencing in critically ill children in Germany

Clinical utility of rapid genome sequencing in critically ill children in Germany - Baby Lion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025163
Enrollment
130
Registered
2023-02-06
Start date
2022-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected monogenetic disease, regardless of organ system involved

Interventions

Group 1: Rapid trio genome sequencing

Sponsors

Institut für Humangenetik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 14 Years

Inclusion criteria

Inclusion criteria: Critically ill child on NICU or PICU with suspected genetic disorder (e.g. complex disease presentation involving two or more organ systems, unusually severe disease manifestation requiring intensive care, other family members with similar symptoms, extremely dystrophic newborns)

Exclusion criteria

Exclusion criteria: Obvious non-genetic causes such as trauma

Design outcomes

Primary

MeasureTime frame
Molecular diagnosis including spectrum of variants and turn around time

Secondary

MeasureTime frame
Clinical utility for physicians and parents, cost analysis

Countries

Germany

Contacts

Public ContactBernd Auber

Institut für Humangenetik

auber.bernd@mh-hannover.de+49 511 532 8719

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026